feed,title,long_url,short_url
Benzinga,"Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome",https://benzinga.com/general/biotech/24/08/40339304/cancer-focused-syros-pharmaceuticals-stops-mid-stage-leukemia-combo-therapy-study-cites-disappoin,https://da.gd/5TXLpi
